Login / Signup

Enfortumab vedotin prolongs overall survival in metastatic urothelial carcinoma following pembrolizumab therapy in real-world data.

Koichi UemuraHiroki ItoRyosuke JikuyaTakuya KondoTomoyuki TatenumaTakashi KawaharaYusuke ItoMitsuru KomeyaKentaro MuraokaHisashi HasumiHiroji UemuraKazuhide Makiyama
Published in: International journal of urology : official journal of the Japanese Urological Association (2024)
EV prolonged OS in mUC following pembrolizumab therapy in real-world data.
Keyphrases
  • electronic health record
  • squamous cell carcinoma
  • data analysis
  • mesenchymal stem cells
  • deep learning
  • smoking cessation